Tissue-specific p53 responses to ionizing radiation and their genetic modification: The key to tissue-specific tumour susceptibility?

Journal of Pathology

Volumn 201, Issue 3, 2003, Pages 377-388

  Coates, Philip J ^a   Lorimore, Sally A ^a   Lindsay, Kirsten J ^a   Wright, Eric G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Apoptosis; Genetics; p53; Radiation; Tumour susceptibility

Indexed keywords

ATM PROTEIN; DNA; PROTEIN BAX; PROTEIN KINASE C; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DAMAGE; CELL TYPE; CONTROLLED STUDY; DNA MODIFICATION; EPITHELIUM CELL; GENETIC POLYMORPHISM; GENOTYPE; HEMATOPOIETIC CELL; HEREDITY; IN VIVO STUDY; INTESTINE; IONIZING RADIATION; LINKAGE ANALYSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; RADIATION EXPOSURE; SPLEEN; TISSUE SPECIFICITY; TRANSACTIVATION; UPREGULATION;

ANIMALS; APOPTOSIS; DISEASE SUSCEPTIBILITY; EPITHELIUM; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIESIS; IMMUNOHISTOCHEMISTRY; INTESTINES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHORYLATION; RADIATION, IONIZING; SERINE; SPLEEN; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0242558968     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1456     Document Type: Article

References (61)

1. Mohrenweiser HW, Jones IM. Uncertainty of response to ionizing radiation due to genotype: potential role for variation in DNA repair genes. Radiat Res 2000; 154: 722-723.
2. Nebert DW. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants. Clin Chem Lab Med 2000; 38: 857-861.
3. Knudsen LE, Loft SH, Autrup H. Risk assessment: the importance of genetic polymorphisms in man. Mutat Res 2001; 482: 83-88.
4. Pharoah PD, Antoniou A, Bobrow M, et al. Polygenic susceptibility to breast cancer and implications for prevention. Nature Genet 2002; 31: 33-36.
5. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75: 631-639.
6. Purdie CA, Harrison DJ, Peter A, et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 1994; 9: 603-609.
7. Donehower LA, Harvey M, Vogel H, et al. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 1995; 14: 16-22.
8. van Meyel DJ, Sanchez-Sweatman OH, Kerkvliet N, et al. Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice. Int J Oncol 1998; 13: 917-922.
9. Szymanska H, Sitarz M, Krysiak E, et al. Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains. Int J Cancer 1999; 83: 674-678.
10. van der Houven van Oordt CW, Smits R, Schouten TG, et al. The genetic background modifies the spontaneous and X-ray-induced tumor spectrum in the Apc1638N mouse model. Genes Chromosomes Cancer 1999; 24: 191-198.
11. Kuperwasser C, Hurlbut GD, Kittrell FS, et al. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol 2000; 157: 2151-2159.
12. Backlund MG, Trasti SL, Backlund DC, et al. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice. Cancer Res 2001; 61: 6577-6582.
13. Ullrich RL, Bowles ND, Satterfield LC, Davis CM. Strain-dependent susceptibility to radiation-induced mammary cancer is a result of differences in epithelial cell sensitivity to transformation. Radiat Res 1996; 146: 353-355.
14. Watson GE, Lorimore SA, Clutton SM, et al. Genetic factors influencing alpha-particle-induced chromosomal instability. Int J Radiat Biol 1997; 71: 497-503.
15. Ponnaiya B, Cornforth MN, Ullrich RL. Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat Res 1997; 147: 121-125.
16. Saito Y, Ochiai Y, Kodama Y, et al. Genetic loci controlling susceptibility to gamma-ray-induced thymic lymphoma. Oncogene 2001; 20: 5243-5247.
17. Kadhim MA, Lorimore SA, Hepburn MD, et al. Alpha-particle-induced chromosomal instability in human bone marrow cells. Lancet 1994; 344: 987-988.
18. Burnet NG, Wurm R, Nyman J, Peacock JH. Normal tissue radiosensitivity - how important is it? Clin Oncol 1996; 8: 25-34.
19. Mothersill CE, O'Malley KJ, Murphy DM, et al. Identification and characterization of three subtypes of radiation response in normal human urothelial cultures exposed to ionizing radiation. Carcinogenesis 1999; 20: 2273-2278.
20. Wright EG. Inherited and inducible chromosomal instability: a fragile bridge between genome integrity mechanisms and tumourigenesis. J Pathol 1999; 187: 19-27.
21. Price EA, Bourne SL, Radbourne R, et al. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet 1997; 23: 237-247.
22. Potten CS. Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature 1977; 269: 518-521.
23. Mori N, Okumoto M, Hart AA, Demant P. Apoptosis susceptibility genes on mouse chromosome 9 (Rapop2) and chromosome 3 (Rapop3). Genomics 1995; 30: 553-557.
24. Weil MM, Stephens LC, Amos CI, et al. Strain difference in jejunal crypt cell susceptibility to radiation-induced apoptosis. Int J Radiat Biol 1996; 70: 579-585.
25. Weil MM, Xia X, Lin Y, et al. Identification of quantitative trait loci controlling levels of radiation-induced thymocyte apoptosis in mice. Genomics 1997; 45: 626-628.
26. Weil MM, Xia C, Xia X, et al. A chromosome 15 quantitative trait locus controls levels of radiation-induced jejunal crypt cell apoptosis in mice. Genomics 2001; 72: 73-77.
27. Nomura T, Kinuta M, Hongyo T, et al. Programmed cell death in whole body and organ systems by low dose radiation. J Radiat Res (Tokyo) 1992; 33(Suppl): 109-123.
28. Mori N, van Wezel T, van der Valk M, et al. Genetics of susceptibility to radiation-induced apoptosis in colon: two loci on chromosomes 9 and 16. Mamm Genome 1998; 9: 377-380.
29. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
30. Lorimore SA, Goodhead DT, Wright EG. The effect of p53 status on the radiosensitivity of haemopoietic stem cells. Cell Death Differentiation 1995; 2: 233-234.
31. Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
32. Wallace M, Coates PJ, Wright EG, Ball KL. Differential posttranslational modification of the tumour suppressor proteins Rb and p53 modulates the rates of radiation-induced apoptosis in vivo. Oncogene 2001; 20: 3597-3608.
33. Midgley CA, Owens B, Briscoe CV, et al. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 1995; 108: 1843-1848.
34. MacCallum DE, Hupp TR, Midgley CA, et al. The p53 response to ionising radiation in adult and developing routine tissues. Oncogene 1996; 13: 2575-2587.
35. Gottlieb E, Haffner R, King A, et al. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J 1997; 16: 1381-1390.
36. Komarova EA, Chernov MV, Franks R, et al. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 1997; 16: 1391-1400.
37. Bouvard V, Zaitchouk T, Vacher M, et al. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene 2000; 19: 649-660.
38. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-3577.
39. Wilson JW, Pritchard DM, Hickman JA, Potten CS. Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest. Am J Pathol 1998; 153: 899-909.
40. Song S, Lambert PF. Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction. Am J Pathol 1999; 155: 1121-1127.
41. Lassus P, Ferlin M, Piette J, Hibner U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J 1996; 15: 4566-4573.
42. Chen X, Ko LJ, Jayaraman L, Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996; 10: 2438-2451.
43. Gorospe M, Cirielli C, Wang X, et al. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997; 14: 929-935.
44. Yu J, Zhang L, Hwang PM, et al. Identification and classification of p53-regulated genes. Proc Natl Acad Sci U S A 1999; 96: 14 517-14 522.
45. Burns TF, Bernhard EJ, El-Deiry WS. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo. Oncogene 2001; 20: 4601-4612.
46. Fei P, Bernhard EJ, El-Deiry WS. Tissue-specific induction of p53 targets in vivo. Cancer Res 2002; 62: 7316-7327.
47. Polyak K, Waldman T, He TC, et al. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996; 10: 1945-1952.
48. Boudreau N, Werb Z, Bissell MJ. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci U S A 1996; 93: 3509-3513.
49. Duttaroy A, Qian JF, Smith JS, Wang E. Up-regulated P21CIP1 expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J Cell Biochem 1997; 64: 434-446.
50. Komarova EA, Christov K, Faerman AI, Gudkov AV. Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene 2000; 19: 3791-3798.
51. Pritchard DM, Potten CS, Korsmeyer SL et al. Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo. Oncogene 1999; 18: 7287-7293.
52. Pritchard DM, Print C, O'Reilly L, et al. Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine. Oncogene 2000; 19: 3955-3959.
53. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187: 112-126.
54. Barlow C, Brown KD, Deng CX, et al. Ann selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nature Genet 1997; 17: 453-456.
55. Wang S, Guo M, Ouyang H, et al. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc Natl Acad Sci U S A 2000; 97: 1584-1588.
56. Okayasu R, Suetomi K, Yu Y, et al. A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res 2000; 60: 4342-4345.
57. Mori N, Matsumoto Y, Okumoto M, et al. Variations in Prkdc encoding the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and susceptibility to radiation-induced apoptosis and lymphomagenesis. Oncogene 2001; 20: 3609-3619.
58. Yang AL, Smith AG, Akhtar R, et al. Low levels of p53 are associated with resistance to tetrachlorodibenzo-p-dioxin toxicity in DBA/2 mice. Pharmacogenetics 1999; 9: 183-188.
59. Lee JM, Abrahamson JL, Kandel R, et al. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 1994; 9: 3731-3736.
60. Venkatachalam S, Shi YP, Jones SN, et al. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 1998; 17: 4657-4667.
61. Muller AJ, Teresky AK, Levine AJ. A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc Natl Acad Sci U S A 2000; 97: 8421-8426.